Contact
searchSearch
HMP Global

Stroke & Neurovascular Interventions Topic Center

Features

Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management
Carotid Artery Disease
Medtronic Launches Full Distribution of the Neuroguard IEP™ System, Establishing a New Era in Treating Patients With Carotid Artery Disease
10/14/2025
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical...
10/14/2025
Vascular Disease Management
Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Interview
Carotid Webs in Young Women: Diagnosis and Treatment
02/12/2025
Bruce Perler, MD
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD, MBA, gave a presentation entitled “Carotid Webs: An Important Etiology of Devastating Strokes, Especially in Young Women.” VDM spoke with Dr Perler about the best ways to diagnose and treat carotid webs.
At VEITH 2024, Bruce Perler, MD,...
02/12/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Stroke Solutions
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
02/05/2025
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features...
02/05/2025
Vascular Disease Management
Dr Korngold
ISET 2025
An Industry Perspective on the Carotid Space
02/03/2025
Ethan C. Korngold, MD
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief medical officer at Abbott Vascular, provides an industry perspective on the evolving role of carotid artery stenting in stroke prevention.
Ethan Korngold, MD, chief...
02/03/2025
Vascular Disease Management
Stroke Advocacy
Philips and Medtronic Advocacy Partnership Aims to Help Accelerate Access to Life-saving Treatments
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the...
10/24/2024
Vascular Disease Management

Videos

Dr Peter Schneider
ISET 2025
Handicapping the CREST 2 Trial: Possible Outcome Scenarios and Impact on Patient Care
03/27/2025
Peter A. Schneider, MD, FACS
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider, MD, discusses his ISET 2025 presentation on the CREST 2 trial, which completed enrollment in August 2024.
In this video, Peter Schneider,...
03/27/2025
Vascular Disease Management
Videos
Urgent Carotid Endarterectomy in a COVID-19 Patient: Standard Approach With Some Adjustments (Video 1)
05/07/2020
05/07/2020
Vascular Disease Management
Videos
Kölbel: Stroke in TEVAR
02/28/2020
Tilo Kölbel, MD
Tilo Kölbel, MD
Tilo Kölbel, MD
02/28/2020
Vascular Disease Management
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD
sponsored video
Gustavo Oderich, MD, Robert Rhee, MD, and Sukgu Han, MD Discuss Evolving Treatment Algorithms in AAA Repair of Short, Angulated Necks
05/01/2026
Gustavo S. Oderich, MD; Robert Rhee, MD; Sukgu Han, MD
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their perspective on the GORE EXCLUDER Conformable AAA Endoprosthesis.
Three experts share their...
05/01/2026
Vascular Disease Management
Drs Gray, Salazar, and Rosenfield speak at ISET 2026
Sponsored Video
What Matters Most in Enhanced Radiation Protection: Occupational Wellness in the Lab With Salus Scientific
04/20/2026
Kenneth Rosenfield, MD, MSc; William A. Gray, MD, FACC, FSCAI; Gloria Salazar, MD, FSIR
Join us as Dr Kenny Rosenfield moderates a session on what matters most in enhanced radiation protection device (ERPD) technology today.
Join us as Dr Kenny Rosenfield moderates a session on what matters most in enhanced radiation protection device (ERPD) technology today.
Join us as Dr Kenny Rosenfield...
04/20/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Surmodics Video Presentation
Sponsored VIdeo
#POUNCEIT! Watch Now: AMP Symposium Videos
03/26/2026
Fadi Saab, MD, FACC, FSCAI; Mahmood Razavi, MD; Lucas Ferrer Cardona, MD; Miguel Montero-Baker, MD; Dean Ferrera, DO; Stylianos Papadakos, MD
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention Symposium session as an expert panel of physicians present cases and discuss their experiences capturing acute or chronic clot in ATK and BTK peripheral arteries with the Pounce™ Thrombectomy Platform.
Watch the Amputation Prevention...
03/26/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Neurovascular Care
Medtronic to Acquire Scientia Vascular, Marrying Access and Therapeutic Portfolios for Neurovascular Care
03/10/2026
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'.
Deal complements Medtronic's...
03/10/2026
Vascular Disease Management
New Stroke Guidelines
New Guideline Expands Stroke Treatment for Adults, Offers First Pediatric Stroke Guidance
02/19/2026
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke recommendations from the American Stroke Association highlight how rapid diagnosis and imaging, extended time windows for stroke treatments and coordinated care involving emergency services, hospitals and health care...
Updated ischemic stroke...
02/19/2026
Vascular Disease Management
Carotid Artery Disease
Medtronic Launches Full Distribution of the Neuroguard IEP™ System, Establishing a New Era in Treating Patients With Carotid Artery Disease
10/14/2025
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical outcomes, the Neuroguard IEP™ System’s unique 3-in-1 design provides enhanced embolic protection when it matters most.1-5,† Medtronic, a global leader in healthcare technology, today announced the full...
Backed by exceptional clinical...
10/14/2025
Vascular Disease Management
Acute Ischemic Stroke
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
03/03/2025
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the U.S. FDA has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Genentech announced that the...
03/03/2025
Vascular Disease Management
Stroke Treatment
Philips, World Bank, and Ukraine Ministry of Health Announce Successful Deployment of Nationwide Acute Stroke Care Upgrade, Helping Thousands of Patients
02/10/2025
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the...
Groundbreaking program that...
02/10/2025
Vascular Disease Management
Stroke Solutions
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
02/05/2025
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features Much-Anticipated SOFIA™ 88 Neurovascular Support Catheter Showcased at ISC Symposium led by Dr. Ameer E. Hassan on Thursday, February 6th ALISO VIEJO, Calif. and LOS ANGELES, Feb. 5, 2025 /PRNewswire/ -- Terumo...
Terumo Neuro Also Features...
02/05/2025
Vascular Disease Management
Stroke Advocacy
Philips and Medtronic Advocacy Partnership Aims to Help Accelerate Access to Life-saving Treatments
10/24/2024
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the newly established World Stroke Organization Advocacy Coalition  Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a...
Both companies also join the...
10/24/2024
Vascular Disease Management
News
Finding a Faster Path to Treatment for Stroke
12/13/2023
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major progress in Philips-sponsored WE-TRUST clinical trial assessing the patient benefits of the ‘Direct to Angio Suite’ treatment pathway December 12, 2023  - On November 29, the WE-TRUST* study – a...
Milestone enrollment marks major...
12/13/2023
Vascular Disease Management
News
First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment
07/18/2023

Philips Press Release

Philips Press Release
Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial.
Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial.
Bicêtre Hospital in Paris,...
07/18/2023
Vascular Disease Management
Stroke
Upfront Diagnostics Launches LVOne Rapid Stroke Blood Test Following Receiving UKCA; First Deployment Begins With London Ambulance Service
05/05/2026
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK – Upfront Diagnostics today announced the commercial launch of LVOne, a rapid blood test designed to help identify large vessel occlusion (LVO) strokes in the pre-hospital setting. The test has received UKCA...
May 5, 2026 – Cambridge, UK –...
05/05/2026
Vascular Disease Management
Pulmonary embolism
Thrombolex Announces Enrollment of 100th Patient in RAPID-PE Clinical Study
05/01/2026
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in Single-Arm Study Evaluating the BASHIR® Endovascular System for Pulmonary Embolism Treatment New Britain, PA, April 30, 2026 — Thrombolex, Inc., a medical device company dedicated to advancing minimally...
Landmark Milestone Reached in...
05/01/2026
Vascular Disease Management
Drug-Eluting Balloons
Cordis Launches SELUTION SLR™ PTA Drug-Eluting Balloon (DEB) in Japan 
04/30/2026
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical trial results demonstrate durable clinical outcomes in a complex patient population, including 81.5% primary patency and 93.8% of patients remaining free from reintervention through three years.(2)
The SELUTION SFA Japan clinical...
04/30/2026
Cath Lab Digest
Below-Ankle Intervention
Saving Limbs Where Others Stop: Cagent Vascular Announces Landmark Peer-Reviewed Data Demonstrating Safety and Efficacy of Serration Remodeling Therapy™ in the Most Challenging Arteries Below-the-Ankle
04/29/2026
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy (SRT) is a novel approach to optimizing luminal gain by gently remodeling the internal elastic lamina through creating a line of weakness to reduce recoil and support durable outcomes.
Serration Remodeling Therapy...
04/29/2026
Vascular Disease Management
Sirolimus-coated Balloons
Concept Medical Announces Preliminary 3-Year Sirona Data at Charing Cross Symposium 2026
04/28/2026
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data Presented at CX-2026 Demonstrate Durable Freedom from Reintervention with MagicTouch PTA in Femoropopliteal Disease London, 21 April 2026: Concept Medical Inc., today announced the presentation of preliminary...
Preliminary 3-Year SIRONA Data...
04/28/2026
Vascular Disease Management
Bioresorbable Scaffolds
REVA Medical Announces Positive MOTIV BTK Trial Results Showing Superiority in Critical Limb-Threatening Ischemia Patients
04/23/2026
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The MOTIV BTK trial met both its primary safety and efficacy endpoints, demonstrating that the MOTIV scaffold provides a statistically significant improvement in clinical outcomes compared to the current standard of care, balloon angioplasty.
The MOTIV BTK trial met both its...
04/23/2026
Cath Lab Digest
BTK Intervention
Abbott Unveils Post-Approval Study Data Demonstrating Potential of Esprit BTK to Treat Significantly Sicker Patients with CLTI and Complex Lesions
04/21/2026
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the Esprit™ BTK Post-Approval Study (PAS) presented at the Charing Cross Symposium in London, UK, revealed promising 30-day results that...
Initial data from the...
04/21/2026
Cath Lab Digest
Chronic Venous Disease
InVera Medical Reports 12-Month Results From Pilot Trial of InVera Infusion Device Showing Vein Closure in 90% of Patients, Statistically Significant Quality of Life Improvements, and Excellent Safety
04/21/2026
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for Chronic Venous Disease Designed to Effectively Eliminate Need for Painful Injections Required for Thermal Ablation
Novel Non-Thermal Procedure for...
04/21/2026
Vascular Disease Management
Femoropopliteal Disease
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
04/21/2026
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif. — Efemoral Medical announced that at the Charing Cross Symposium in London, UK, EFEMORAL I Principal Investigator Prof. Andrew Holden of Auckland, NZ, presented the long-term results of the first 40 patients...
LOS ALTOS, Calif....
04/21/2026
Cath Lab Digest
Arteriovenous Fistula
Medtronic Reports Strong 12-Month Real-World Outcomes for IN.PACT™ AV Drug-Coated Balloon†
04/16/2026
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary cohort shows 70.2% target lesion primary patency consistent with pivotal randomized controlled trial results in a challenging population1 Medtronic, a global leader in healthcare technology, today announced...
Post-approval study’s primary...
04/16/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use